주요 내용으로 건너 뛰기
/ 자료 / 컨퍼런스 / BioTechX EU

BioTechX EU

BioTechX EU
We are excited to be presenting at this conference!

Large Language Models Track: Moving from Hype to Reality in Pharmaceutical AI Applications​

Sean McGee, MS

|

Director of Product

With over a year having passed since the beginning of the purported “AI Revolution,” a question remains: how can life science companies best utilize this technology to accelerate safer and more efficacious therapeutics to patients? Currently, Andreesen Horowitz estimates that 73% of pharmaceutical companies are struggling to adopt AI effectively. The key lies in defining concrete use cases that maximize the capability of the AI technology to assist scientists at the bench, data scientists in the dry lab, to medical writers working with regulatory agencies. This presentation will cover three examples:

  • Utilizing GPTs to support structured content authoring in medical writing and regulatory submissions
  • Automating data transformation to support eCTD standardization
  • Expanding the scope and improving the validation of the creation of quantitative systems pharmacology (QSP) models to improve target ID, PK/PD, and clinical trial design

Digital Health Technology Reimbursement: A Comparative Analysis of Five European Countries

Kurt Neeser

|

Sr. Director of Evidence & Accesss

자료

Before or after your visit to our booth, explore our “molecule to market” solution ecosystem through the resources below.

신약 개발

Accelerate drug discovery with the D360 Scientific Informatics Platform

Translational and Preclinical

Mechanistic Modeling – PBPK

Mechanistic Modeling – QSP

PK/PD Analysis and Pharmacometrics

Non-Clinical Data Analysis and Toxicology

Clinical Data Management and Biometrics

Regulatory Sciences

Document creation

Package submission

Evidence, Value and Access

Certara.AI – GPTs specialized for the life sciences

Powered by Translations.com GlobalLink Web Software